1Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Soandinavian Simvastatin Survival Study(4S). Lancet 1994;344:1383 - 1389.
2Gould AL, Rossouw JE, Santanello NC, et al. Cholesterol reduction yields clinical benefits:a new lood at old data. Circulation 1995;91:2274 - 2282.
3Oliver MF. Doubts about preventing coronary heart disease.Multiple interventions in middle aged men may do more harm than good. Br Med J 1992;304:393- 394.
4The Long-Term Intervention with Pravastatin in Ischaemic Disease(LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol level. N Engl J Med 1998; 339:1349- 1357.
5Downs JR, Clearfield M, Weis, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TesCAPS. JAMA 1998, 97:946 - 952.
6Schwartz GG. Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early tecurrent ischaemic events in acute coronary syndromes: the MIRACL Study, a randomized controlled trial. JAMA2001; 285:1711 - 1718.
7Shepherd J, Blauw GJ, Feyter P, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 2002; 360:1623 - 1630.
8Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536high-risk indivisuals: a randomized placebo-controlled trial. Lancet2002; 360: 7 - 22.
9Trandberg TE, Pyorala K, Cook T, et al. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study(4S). Lancet 2004;364:771 - 777.
